05 Jul 2009 Gulf News
 

Health ministry advises care when buying painkillers

  • Text size
  •  
  •  

Sunday, Jul 05, 2009

Gulf News

Abu Dhabi: The Ministry of Health (MoH)Ministry of Health (MoH)Loading... has urged people to pay special attention to warning labels and enclosed leaflets for over-the-counter medications, especially when purchasing painkillers that promise quick relief from high temperature and minor aches and pains.

A senior official at the MoH stressed that reading enclosed leaflets would make buyers of drugs aware of potential side effects and the exact recommended dosages.

The warning is in response to a series of surveys conducted by the US Food and Drug Administration (FDA), who assembled 37 experts last week to recommend ways to avoid cases of fatal overdoses when using drugs like acetaminophen (commonly used to relieve pain and reduce fever and considered the leading cause of liver failure in the US - sending nearly 56,000 people to the emergency room annually).

Due to their side effects on the liver, a ban was recently imposed on two of the most popular prescription painkillers in the world, Vicodin and Percocet.

The ministry has also called for cutting back on purchases of daily doses of over-the-counter drugs that contain acetaminophen, such as Extra Strength Tylenol and Excedrin for instance. Both drugs are popular among adults and children across the UAE.

Dr Ameen Al Amiri, the director of the Medical Practices and Licensing Department at the MoH told Gulf News that the UAE is one of the first countries to take action to limit the damage from over-the-counter medications. The MoH, he said, is in close contact with pharmaceutical companies to make sure that the necessary warning labels are prominently displayed on packages and that dosages are clearly mentioned in enclosed leaflets.

"The ministry has a Drug and Registration Monitoring Department that makes sure the necessary steps are taken and that clear warnings are placed on medications sold across the UAE," said Al Amiri.

Doctors in the UAE feel that lowering the maximum prescribable dose of Tylenol and eliminating prescription drugs such as Vicodin and Percocet is necessary.

"Vicodin and Percocet are restricted drugs in this part of the world anyway. But I do agree that safety restrictions should be applied on their use," Dr Ashok Kapoor, chairman of Getwell Medical Centre in Dubai, told Gulf News.

"They contain a component known as deoxycodein, which has a sedative effect and can impair your efficiency. It acts on your nervous system. For example, while driving, these drugs can induce sleep," he said.

According to Dr Kapoor, such drugs act as painkillers and are prescribed for flu and body ache. "Heavy dosage can affect vital organs. One cannot buy these drugs over the counter. One needs special prescriptions to buy these drugs. We avoid prescribing it as much as possible."

Dr R.V.S. Ranavat of the Ramada Medical Centre in Dubai voiced a similar opinion. According to him, deoxycodein is completely banned in all Arab countries. "It is next to morphine; there is a special prescription a copy of which goes to the MoH, another to the pharmacist, one copy is kept with us and, towards the end of every month, doctors have to provide a detailed report to the ministry on the patient's history and the number of occasions these drugs were prescribed," he said.

Do you read the leaflets before consuming prescription drugs? Before purchasing medication, do you consult with a doctor or pharmacist? Or do you just buy them off the shelf?

By Dina El Shammaa and Sunita Menon, Staff Reporters

© Gulf News 2009. All rights reserved.

x DISCLAIMER

Zawya is a distributor (and not a publisher) of content supplied by third parties and subscribers. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by those third parties, including information providers, subscribers or other users of the Service, are those of the respective author(s) or distributor(s) and not of the Company. The Company neither endorses nor is responsible for the accuracy or reliability of any opinion, advice or statement made on the Service by anyone other than authorized Service employee spokespersons while acting in their official capacities. The Company is not responsible for any infringement of intellectual property rights or breach of any applicable law or regulation, including regulation in relation to financial services or the distribution of financial products, defamation, data protection, telecommunications (including regulations relating to excessive use, spamming or other abusive activities) or obscene, offensive or illegal content). Under no circumstances will the Company be liable for any loss or damage caused by a member's reliance on information obtained through the Service. It is the responsibility of member to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content available through the Service. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content.

Read the full Member Agreement
http://www.zawya.com/legal/NewsLetter.cfm?name=disclaimer
Access to this article is subject to specific terms and condition.
 
 

Post a Comment

 
  • Comment Title (optional)
  • Express your views or tell us more about this article
  • First Name
  • Last Name
  • Email Address
  • Company Name (optional)
Leave this field empty
 
 
Zawya Comment Policy
 
  1. Zawya encourages you to add a comment to this discussion. You agree that when you add content to this discussion your comments will not:
    1.1   Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
    1.2   Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
    1.3   Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
    1.4   Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
    1.5   Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
    1.6   Give the impression that they represent Zawya.
    1.7   Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse.
  2. The content posted on www.zawya.com is created by members of the public. The views expressed are theirs and unless specifically stated are not those of Zawya. Zawya reserves the right to review all comments prior to posting and edit or delete any contribution, but Zawya is not responsible for and can not be held liable for any content posted by members of the public on www.zawya.com.
  3. Zawya is not responsible for the availability or content of any third party sites that are accessible through www.zawya.com. Any links to third party websites from www.zawya.com do not amount to any endorsement of that site by Zawya and any use of that site by you is at your own risk.
  4. By submitting your comment, you hereby give Zawya the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comments worldwide, in perpetuity.